John Overdeck’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Sell
6,400
-800
-11% -$145K ﹤0.01% 3295
2026
Q1
$960K Buy
+7,200
New +$1.15M ﹤0.01% 3289
2022
Q1
Sell
-6,000
Closed -$1.91M 3703
2021
Q4
$1.91M Buy
6,000
+2,300
+62% +$684K ﹤0.01% 1952
2021
Q3
$1M Buy
3,700
+2,700
+270% +$713K ﹤0.01% 2619
2021
Q2
$253K Sell
1,000
-4,000
-80% -$1M ﹤0.01% 3628
2021
Q1
$1.17M Buy
5,000
+3,100
+163% +$691K ﹤0.01% 2167
2020
Q4
$404K Buy
+1,900
New +$392K ﹤0.01% 2648
2020
Q3
Sell
-5,100
Closed -$908K 3388
2020
Q2
$908K Buy
5,100
+100
+2% +$17K ﹤0.01% 1593
2020
Q1
$699K Sell
5,000
-1,600
-24% -$214K 0.01% 1695
2019
Q4
$896K Buy
6,600
+2,900
+78% +$365K ﹤0.01% 2287
2019
Q3
$406K Sell
3,700
-6,300
-63% -$816K ﹤0.01% 2719
2019
Q2
$1.43M Buy
10,000
+8,000
+400% +$1.1M ﹤0.01% 1666
2019
Q1
$284K Buy
+2,000
New +$270K ﹤0.01% 2636
2018
Q2
Sell
-3,900
Closed -$317K 3512
2018
Q1
$317K Sell
3,900
-4,400
-53% -$354K ﹤0.01% 2745
2017
Q4
$636K Buy
+8,300
New +$599K ﹤0.01% 2272

Other funds holding MOH

John Overdeck's MOH Position: Q2 2026 in Review

John Overdeck reduced its Molina Healthcare (MOH) stake by 6.2% in Q2 2026, selling an estimated $15.3M and leaving 1,266,338 shares worth $290M. The position accounts for 0.21% of the portfolio, ranked #99.

John Overdeck first reported a position in MOH in Q2 2013 and has held it in 39 quarters since. 597 funds tracked by Wall St. Rank hold MOH as of Q2 2026.

  • John Overdeck held 1,266,338 shares of Molina Healthcare worth $290M as of Q2 2026.
  • John Overdeck sold 84,357 Molina Healthcare shares in Q2 2026, an estimated $15.3M.
  • Molina Healthcare made up 0.21% of John Overdeck's portfolio in Q2 2026, its #99 holding.
  • John Overdeck first reported a position in Molina Healthcare in Q2 2013 and has held it in 39 quarters since.
  • 597 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.